Literature DB >> 20714787

Nutraceutical use in late-stage cancer.

Michael J Wargovich1, Jay Morris, Vondina Brown, Jane Ellis, Britt Logothetis, Rebecca Weber.   

Abstract

Access to a wealth of information on the internet has led many cancer patients to use complementary methods as an adjunct to traditional therapy for cancer, with, and more often, without informing their primary caregiver. Of the common complementary modalities, the use of dietary supplements appears to be highly prevalent in patients in active treatment for cancer, and later in cancer survivors. Emerging research suggests that some plant-based agents may, indeed, impact late-stage cancer, influencing molecular processes corrupted by tumor cells to evade detection, expand clonally, and invade surrounding tissues. The intent of this article is to review some of the current science underpinning the use of nutraceuticals in the latter stages of cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20714787      PMCID: PMC3388613          DOI: 10.1007/s10555-010-9240-5

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  82 in total

Review 1.  Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds.

Authors:  Marjan Nassiri-Asl; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2009-09       Impact factor: 5.878

Review 2.  Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Authors:  Tze-chen Hsieh; Joseph M Wu
Journal:  Biofactors       Date:  2010 Sep-Oct       Impact factor: 6.113

Review 3.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

4.  Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.

Authors:  M W Roomi; J C Monterrey; T Kalinovsky; M Rath; A Niedzwiecki
Journal:  Oncol Rep       Date:  2010-09       Impact factor: 3.906

5.  Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.

Authors:  Ajaikumar B Kunnumakkara; Parmeswaran Diagaradjane; Preetha Anand; Kuzhuvelil B Harikumar; Harikumar B Kuzhuvelil; Amit Deorukhkar; Juri Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

6.  Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.

Authors:  P Manikandan; G Vinothini; R Vidya Priyadarsini; D Prathiba; S Nagini
Journal:  Invest New Drugs       Date:  2009-10-23       Impact factor: 3.850

Review 7.  Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

Authors:  Francesca Borrelli; Angelo A Izzo
Journal:  AAPS J       Date:  2009-10-27       Impact factor: 4.009

8.  [6]-Gingerol induces reactive oxygen species regulated mitochondrial cell death pathway in human epidermoid carcinoma A431 cells.

Authors:  Nidhi Nigam; Kulpreet Bhui; Sahdeo Prasad; Jasmine George; Yogeshwer Shukla
Journal:  Chem Biol Interact       Date:  2009-05-27       Impact factor: 5.192

Review 9.  Role of nutrition in gastrointestinal oncological patients.

Authors:  R Di Luzio; S Moscatiello; G Marchesini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

10.  Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.

Authors:  Suzanna M Zick; Mack T Ruffin; Julia Lee; Daniel P Normolle; Rivka Siden; Sara Alrawi; Dean E Brenner
Journal:  Support Care Cancer       Date:  2008-11-13       Impact factor: 3.603

View more
  7 in total

Review 1.  Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.

Authors:  Devarajan Nalini; Jayaraman Selvaraj; Ganesan Senthil Kumar
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-13       Impact factor: 4.553

2.  Battling Chemotherapy-induced Nausea and Vomiting in Cancer Palliative Care.

Authors:  Dilip Gude
Journal:  Indian J Palliat Care       Date:  2011-01

3.  Anticancer Properties of Chrysin on Colon Cancer Cells, In vitro and In vivo with Modulation of Caspase-3, -9, Bax and Sall4.

Authors:  Maliheh Bahadori; Javad Baharara; Elaheh Amini
Journal:  Iran J Biotechnol       Date:  2016-09       Impact factor: 1.671

4.  Colorectal Cancer Cells Increase the Production of Short Chain Fatty Acids by Propionibacterium freudenreichii Impacting on Cancer Cells Survival.

Authors:  Marta R Casanova; João Azevedo-Silva; Ligia R Rodrigues; Ana Preto
Journal:  Front Nutr       Date:  2018-05-24

5.  Variable inhibitory effect of herbal supplements of different brands on human P450 CYP1A2.

Authors:  Sompon Wanwimolruk; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2012-02-02       Impact factor: 4.068

Review 6.  Nutraceuticals as potential therapeutic agents for colon cancer: a review.

Authors:  Palaniselvam Kuppusamy; Mashitah M Yusoff; Gaanty Pragas Maniam; Solachuddin Jauhari Arief Ichwan; Ilavenil Soundharrajan; Natanamurugaraj Govindan
Journal:  Acta Pharm Sin B       Date:  2014-05-03       Impact factor: 11.413

7.  Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells.

Authors:  Eswara Murali Satyavarapu; Ranjita Das; Chandan Mandal; Asima Mukhopadhyay; Chitra Mandal
Journal:  Cell Death Dis       Date:  2018-09-17       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.